Developer docs
API playgroundTry for free, no card

Search company profiles

Oncospace

Full company profile

uuid00033tc

Namestring
Oncospace
Websiteurl
oncospace.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Oncospace is a Baltimore-based medical device and software company, founded in 2019, that developed AI-powered radiation oncology software for clinical decision support, treatment planning analytics, and quality assurance. Its technology targets a narrow vertical: hospitals, cancer centers, and radiation oncology clinics seeking to improve radiotherapy treatment planning accuracy, QA workflows, and patient safety. The company's core product is an AI-focused quality enablement platform purpose-built for radiation oncology workflows, distinguishing it from generic AI vendors by its domain specialization.

Pre-acquisition, Oncospace operated as a small private company with 11-50 employees, pursuing a vertical go-to-market into radiation oncology providers. Revenue model, pricing, and detailed customer counts are not publicly disclosed. The company was funded primarily through non-dilutive grants from the National Science Foundation — approximately $1.258 million across 2019 ($225K), 2020 ($25K), and 2021 ($1.008M) — rather than traditional venture capital, indicating a research-and-development-heavy capital structure in its early years.

On April 30, 2025, Oncospace was acquired by Sun Nuclear Corporation, a Mirion Technologies company, integrating its AI capabilities into Sun Nuclear's established radiation oncology QA portfolio alongside products such as SunCHECK, Daily QA 4 Pro, and Plan AI. Following the acquisition, Oncospace operates as a brand within Sun Nuclear's ecosystem, with marketing and global distribution handled through Sun Nuclear's existing sales, training, and support channels rather than independently.

Short descriptiontext

Oncospace is an AI-powered radiation oncology software provider offering clinical decision support and quality assurance solutions for hospitals, cancer centers, and radiation therapy clinics, acquired by Sun Nuclear (a Mirion company) in April 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBaltimore, United States
HQ citystring
Baltimore
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
radiation oncology software, treatment planning QA, clinical decision support, radiation therapy analytics, patient safety software
Industry2 codes
PRIMARYHLAKAFAC
Radiation Oncology
SECONDARYHLAHABAH
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code2 codes
  • Irradiation Apparatus Manufacturing334517
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Radiation Oncology Software
No data
Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Oncospace develops AI-focused radiation oncology software that provides clinical decision support and data analytics for radiation therapy treatment planning and quality assurance. The software is designed to enhance treatment planning accuracy and patient safety optimization for hospitals, cancer centers, and radiation oncology clinics. Following Sun Nuclear's April 2025 acquisition, Oncospace's capabilities are integrated into Sun Nuclear's radiation oncology quality management portfolio.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Oncospace is an AI-focused radiation oncology software provider acquired by Sun Nuclear in April 2025. Following the acquisition, Oncospace operates as a brand within Sun Nuclear's radiation therapy quality management ecosystem, complementing Sun Nuclear's existing portfolio of QA products including SunCHECK, Daily QA, and Plan AI. The specific product offerings, modules, and technical capabilities of Oncospace's software platform are not detailed in the available source data.

Product and service1 record
1Oncospace AI Radiation Oncology Software
CategoryRadiation Oncology Software
Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-30
Description

Sun Nuclear, a Mirion Technologies company, acquired Oncospace on April 30, 2025. Oncospace is an AI-focused radiation oncology software provider. The acquisition integrates Oncospace's AI capabilities into Sun Nuclear's radiation oncology quality management solutions portfolio, enhancing patient safety offerings.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Oncospace

Radiation Oncology Softwareoncospace.com

Oncospace is an AI-powered radiation oncology software provider offering clinical decision support and quality assurance solutions for hospitals, cancer centers, and radiation therapy clinics, acquired by Sun Nuclear (a Mirion company) in April 2025.

What Oncospace does

Oncospace is a Baltimore-based medical device and software company, founded in 2019, that developed AI-powered radiation oncology software for clinical decision support, treatment planning analytics, and quality assurance. Its technology targets a narrow vertical: hospitals, cancer centers, and radiation oncology clinics seeking to improve radiotherapy treatment planning accuracy, QA workflows, and patient safety. The company's core product is an AI-focused quality enablement platform purpose-built for radiation oncology workflows, distinguishing it from generic AI vendors by its domain specialization.

Pre-acquisition, Oncospace operated as a small private company with 11-50 employees, pursuing a vertical go-to-market into radiation oncology providers. Revenue model, pricing, and detailed customer counts are not publicly disclosed. The company was funded primarily through non-dilutive grants from the National Science Foundation — approximately $1.258 million across 2019 ($225K), 2020 ($25K), and 2021 ($1.008M) — rather than traditional venture capital, indicating a research-and-development-heavy capital structure in its early years.

On April 30, 2025, Oncospace was acquired by Sun Nuclear Corporation, a Mirion Technologies company, integrating its AI capabilities into Sun Nuclear's established radiation oncology QA portfolio alongside products such as SunCHECK, Daily QA 4 Pro, and Plan AI. Following the acquisition, Oncospace operates as a brand within Sun Nuclear's ecosystem, with marketing and global distribution handled through Sun Nuclear's existing sales, training, and support channels rather than independently.

Oncospace firmographics

Firmographics
Name
Oncospace
Website
https://oncospace.com
Company type
Private
Founded year
2019
Operating status
Acquired
Headcount range
1–10 employees
Short description
Oncospace is an AI-powered radiation oncology software provider offering clinical decision support and quality assurance solutions for hospitals, cancer centers, and radiation therapy clinics, acquired by Sun Nuclear (a Mirion company) in April 2025.
Ownership category
akta.pro rank

Oncospace industry classification

Industry
Product category
Radiation Oncology Software
NAICS
Irradiation Apparatus Manufacturing (334517), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAKAFAC
Radiation Oncology
SECONDARYHLAHABAH
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Radiation oncology software
  • Treatment planning QA
  • Clinical decision support
  • Radiation therapy analytics
  • Patient safety software

Where Oncospace is headquartered

Location

Headquarters

HQ city
Baltimore
HQ country
United States
HQ region
North America

Markets served

Oncospace business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Oncospace product offering

Product offering

Core offering

Oncospace develops AI-focused radiation oncology software that provides clinical decision support and data analytics for radiation therapy treatment planning and quality assurance. The software is designed to enhance treatment planning accuracy and patient safety optimization for hospitals, cancer centers, and radiation oncology clinics. Following Sun Nuclear's April 2025 acquisition, Oncospace's capabilities are integrated into Sun Nuclear's radiation oncology quality management portfolio.

Product overview

Oncospace is an AI-focused radiation oncology software provider acquired by Sun Nuclear in April 2025. Following the acquisition, Oncospace operates as a brand within Sun Nuclear's radiation therapy quality management ecosystem, complementing Sun Nuclear's existing portfolio of QA products including SunCHECK, Daily QA, and Plan AI. The specific product offerings, modules, and technical capabilities of Oncospace's software platform are not detailed in the available source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Oncospace AI Radiation Oncology Software

Companies that use Oncospace

Customer profile

Segments1 record

Ideal customer profiles1 record

Oncospace technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Oncospace partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sun NuclearcoreStrategic or Co-development Partner · 30 April 2025Sun Nuclear, a Mirion Technologies company, acquired Oncospace on April 30, 2025. Oncospace is an AI-focused radiation oncology software provider. The acquisition integrates Oncospace's AI capabilities into Sun Nuclear's radiation oncology quality management solutions portfolio, enhancing patient safety offerings.

Recent moves5 records

Expansion highlights4 records

Oncospace competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

Oncospace financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Oncospace leadership team

Management profile

Number of profiles

Profiles2 records

Oncospace funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Oncospace M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oncospace

What does Oncospace do?

Oncospace develops AI-focused radiation oncology software that provides clinical decision support and data analytics for radiation therapy treatment planning and quality assurance. The software is designed to enhance treatment planning accuracy and patient safety optimization for hospitals, cancer centers, and radiation oncology clinics. Following Sun Nuclear's April 2025 acquisition, Oncospace's capabilities are integrated into Sun Nuclear's radiation oncology quality management portfolio.

Is Oncospace a public or private company?

Oncospace is a private company. It is classified as corporate owned and is currently acquired.

When was Oncospace founded?

Oncospace was founded in 2019. It employs 1 to 10 people.

Where is Oncospace based?

Oncospace is headquartered in Baltimore, United States, in the North America region.

Does Oncospace have an API?

No public API is recorded for Oncospace.

What industry is Oncospace in?

Oncospace's product category is Radiation Oncology Software. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 334517 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals